Medical device industry, advocates weigh in on proposed expedited approval process

NewsGuard 100/100 Score
The Hill's Healthwatch blog reports that consumer groups and device makers are weighing in on a proposal to expedite the approval process for some medical devices. "While the Advanced Medical Technology Association (AdvaMed) argues for modernizing the process while arguing that it's safe, Public Citizen counters that it 'has failed to consistently protect the public health.' The comments come as the Food and Drug Administration is considering more than 60 changes to the expedited approval process for low- and moderate-risk devices, known as pre-market review or 510(k)." A consumer group says the FDA should do more to "keep dangerous and ineffective medical devices from the market" (Pecquet, 10/5).

CQ HealthBeat: "The [FDA] proposed significant changes in August, which were outlined in two lengthy documents. The ideas resulted from concerns over whether the current review program takes a stringent enough approach to evaluating the safety and effectiveness of products and whether a lack of consistency at the agency is causing uncertainty about the process" (Adams, 10/5).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Empowering Change: How Hologic is Shaping the Future of Women's Healthcare